butabarbital decreases consequences of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Intently. Coadministration of CYP3A4 inducers may lessen sufentanil amounts and efficacy, potentially precipitating withdrawal syndrome in individuals who may have designed Bodily dependence to sufentanil. Disconti